GlassScriptPhysician profile
Kevin S Tan
NPI 1063654978
$9,647.47
in general payments reported to CMS, 2019-2025
27 companies · $2,240 in 2025
The $2,240 reported for 2025 was more than what 89% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,316 · 2020: $503 · 2021: $815 · 2022: $1,177 · 2023: $2,252 · 2024: $1,345 · 2025: $2,240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,336 · Long Term Medical Supply Or Device Loan: $501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,335.84 |
| Long Term Medical Supply Or Device Loan | $501.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,888.88 | 2019-2025 | Clareon, Rocklatan, Hydrus Microstent |
| Abbvie INC. | $1,003.18 | 2022-2025 | Durysta, Lumigan, Alphagan P |
| Sight Sciences, INC. | $871.47 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Glaukos Corporation | $520.28 | 2019-2023 | |
| Carl Zeiss Meditec USA, INC. | $501.40 | 2023 | Lumera |
| Oyster Point Pharma, INC. | $450.76 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Allergan, INC. | $433.93 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $328.78 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Novartis Pharmaceuticals Corporation | $282.34 | 2020-2023 | |
| Mallinckrodt Hospital Products INC. | $269.97 | 2024-2025 | Acthar |
| Tarsus Pharmaceuticals, INC. | $264.64 | 2024-2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $258.73 | 2020-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $255.50 | 2019-2023 | Tecnis Iol, Tecnis Iol |
| Sun Pharmaceutical Industries INC. | $204.01 | 2019-2025 | Cequa |
| Biotissue Holdings INC. | $179.43 | 2019-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $174.01 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $161.38 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $154.48 | 2025 | Purified Cortrophin Gel |
| Thea Pharma INC. | $129.34 | 2023-2025 | Iyuzeh |
| Dompe US, INC. | $89.40 | 2022-2025 | Oxervate |
| Rxsight INC | $47.02 | 2022-2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Carl Zeiss Meditec, INC. | $44.08 | 2019 | |
| Ivantis, INC | $40.32 | 2021 | |
| Coopervision INC. | $31.81 | 2019 | |
| Philips North America LLC | $24.50 | 2021 | |
| Rayner Intraocular Lenses Limited | $20.51 | 2025 | Rayone Aspheric, Rayner Cataract Set 1, Rayone Emv |
| Eyevance Pharmaceuticals LLC | $17.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.